Form 4: Moderna Director's Entity Exercises, Sells Shares

An entity controlled by Moderna Director Noubar Afeyan exercised options and immediately sold 23,853 shares of Moderna common stock on December 11, 2025.

Summary

• Noubar Afeyan, a Director of Moderna, Inc., reported transactions through Flagship Pioneering, Inc., an entity where he serves as CEO and sole stockholder.
• On December 11, 2025, Flagship Pioneering, Inc. exercised options to acquire 23,853 shares of Moderna common stock at an exercise price of $10.90 per share.
• Concurrently, Flagship Pioneering, Inc. sold 23,853 shares of Moderna common stock at a price of $29.485 per share.
• The exercised options were fully vested and were set to expire on February 23, 2026.
• Following these transactions, Flagship Pioneering, Inc. indirectly holds 27,777 shares, Flagship Ventures Fund IV, L.P. indirectly holds 3,880,328 shares, and Flagship Ventures Fund IV-Rx, L.P. indirectly holds 747,897 shares.
• Afeyan also directly holds 2,224,015 shares.
• Afeyan disclaims beneficial ownership of shares held by Flagship Pioneering, Flagship Fund IV, and Flagship Fund IV-Rx, except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction involving the exercise of expiring options and a subsequent sale. While the sale reduces direct exposure, it's a common and often pre-planned event, not necessarily indicative of negative sentiment towards the company's future. The profitability of the transaction for the insider's entity is a minor positive.

Positives

• The exercise of options at $10.90 and subsequent sale at $29.485 indicates a profitable transaction for the entity controlled by the director.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-arranged, non-discretionary sale, which can reduce concerns about opportunistic insider trading.

Negatives

• The sale of shares by an insider's affiliated entity reduces the direct equity exposure of that entity to Moderna, which could be perceived as a minor negative, although it is often part of a pre-planned strategy.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which primarily reports past transactions.

Industry Context

This Form 4 reports a routine insider transaction involving the exercise of expiring stock options and a subsequent sale of shares. Such transactions are common for executives and directors, often executed under pre-arranged Rule 10b5-1 plans, and do not typically reflect a change in the company's strategic direction or broader industry position.

Related Party Transactions

• The transactions were conducted by Flagship Pioneering, Inc., an entity where Noubar Afeyan is the CEO and sole stockholder, making it a related party.
• Flagship Pioneering is contractually obligated to transfer proceeds of any sale to Flagship Fund IV, L.P., another entity where Afeyan has a disclaimed beneficial interest.

Stakeholder Impact

• Shareholders: The sale of shares by an insider's affiliated entity could be viewed neutrally as a routine event or slightly negatively if interpreted as reduced insider confidence, though the Rule 10b5-1 plan mitigates this.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where an entity associated with a director exercised expiring stock options and immediately sold the acquired shares. Such transactions, especially when executed under a Rule 10b5-1 plan, are typically pre-scheduled and do not reflect a change in the director's or the company's fundamental outlook. The transaction itself is profitable for the insider's entity, but it does not provide new information to warrant a change in investment thesis for Moderna. Therefore, a 'hold' recommendation is appropriate as this filing does not present new material information to alter an existing investment position.

Keywords

Moderna, MRNA, Noubar Afeyan, Insider Transaction, Form 4, Stock Option Exercise, Share Sale, Flagship Pioneering, Director Transaction